Fixed Drug Eruption

An Underrecognized Cutaneous Adverse Drug Reaction in a 7-Year-Old Male - A Case Report

Authors

  • Rex David N. Nuico, MD, DPPS University of Santo Tomas Hospital, Manila, Philippines https://orcid.org/0009-0006-7610-2574
  • Agnes G. Andaya, MD, FPPS, FPSAAI University of Santo Tomas Hospital, Manila, Philippines

DOI:

https://doi.org/10.70552/pjaai.26.2.18200

Keywords:

fixed drug eruption, adverse drug reaction, paracetamol, drug hypersensitivity, case report

Abstract

Fixed drug eruptions (FDEs) are a distinctive delayed hypersensitivity reaction characterized by recurrent lesions at the same anatomical sites upon re-exposure to the culprit drug. Although paracetamol is widely used and generally considered safe at therapeutic doses, paracetamol-induced FDE is uncommon and often underrecognized. We report a case of a 7-year-old Filipino male with no history of atopy who developed recurrent episodes of pruritic, well-demarcated erythematous patches that consistently appeared within minutes after paracetamol intake and evolved into persistent hyperpigmented lesions at identical sites. Physical examination revealed multiple well-demarcated hyperpigmented patches without mucosal involvement. A supervised one-step oral paracetamol challenge at a low weight-based dose (10 mg/kg) reproduced pruritus and erythema over pre-existing lesions within 10 minutes, confirming the diagnosis of paracetamol-induced fixed drug eruption. This case emphasizes that paracetamol can cause FDE in children, highlighting the importance of recognizing lesion recurrence patterns, confirming diagnosis through a supervised challenge when appropriate, and ensuring avoidance of the offending drug with counseling on safe alternatives to prevent recurrence.

Author Biographies

Rex David N. Nuico, MD, DPPS , University of Santo Tomas Hospital, Manila, Philippines

Section of Allergy, Asthma, and Immunology, Department of Pediatrics, University of Santo Tomas Hospital, Manila, Philippines

Agnes G. Andaya, MD, FPPS, FPSAAI, University of Santo Tomas Hospital, Manila, Philippines

Section of Allergy, Asthma, and Immunology, Department of Pediatrics, University of Santo Tomas Hospital, Manila, Philippines

References

1. Ardern-Jones M. Common cutaneous drug reactions. BMJ Best Practice. 2024. Accessed February 15, 2026. https://bestpractice.bmj.com/topics/en-gb/368

2. Gosiengfiao V, Alberto N. Cutaneous drug reactions and their causative agents as seen at the Philippine General Hospital Section of Dermatology from January 2001 to March 2003. J Philipp Dermatol Soc. 2005;14(1):49-52.

3. Heelan K, Shear NH. Cutaneous drug reactions in children: an update. Paediatr Drugs. 2013;15(6):493-503. https://pubmed.ncbi.nlm.nih.gov/23842849 https://doi.org/10.1007/s40272-013-0039-z

4. Khaled A, Kharfi M, Hamida MB, et al. Cutaneous adverse drug reactions in children. A series of 90 cases. Tunis Med. 2012;90(1):45-50. https://pubmed.ncbi.nlm.nih.gov/22311448

5. Dilek N, Ozkol H, Akbaş A, et al. Cutaneous drug reactions in children: A multicentric study. Postepy Dermatol Alergol. 2014;31(6):368-71. https://pubmed.ncbi.nlm.nih.gov/25610351 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293388 https://doi.org/10.5114/pdia.2014.43881

6. McClatchy J, Yap T, Nirenberg A, Scardamaglia L. Fixed drug eruptions – the common and novel culprits since 2000. J Dtsch Dermatol Ges. 2022;20(10):1289-1302. https://pubmed.ncbi.nlm.nih.gov/36210056 https://doi.org/10.1111/ddg.14870

7. Shaker G, Mehendale T, De La Rosa C. Fixed drug eruption: an underrecognized cutaneous manifestation of a drug reaction in the primary care setting. Cureus. 2022;14(8):e28299. https://pubmed.ncbi.nlm.nih.gov/36034061 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397151 https://doi.org/10.7759/cureus.28299

8. Heng YK, Yew YW, Lim DS, Lim YL. An update of fixed drug eruptions in Singapore. J Eur Acad Dermatol Venereol. 2015;29(8):1539-44. https://pubmed.ncbi.nlm.nih.gov/25491106 https://doi.org/10.1111/jdv.12919

9. Thompson G, Bundell C, Lucas M. Paracetamol allergy in clinical practice. Aust J Gen Pract. 2019;48(4):216-9. https://pubmed.ncbi.nlm.nih.gov/31256492 https://doi.org/10.31128/AJGP-08-18-4689

10. Popiołek I, Piotrowicz-Wójcik K, Porebski G. Hypersensitivity reactions in serious adverse events reported for paracetamol in the EudraVigilance Database, 2007-2018. Pharmacy (Basel). 2019;7(1):12. https://pubmed.ncbi.nlm.nih.gov/30658389 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473647 https://doi.org/10.3390/pharmacy7010012

11. Fathallah N, Ben Salem C, Slim R, Boussofara L, Ghariani N, Bouraoui K. Acetaminophen-induced cellulitis-like fixed drug eruption. Indian J Dermatol. 2011;56(2):206-8. https://pubmed.ncbi.nlm.nih.gov/21716550 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108524 https://doi.org/10.4103/0019-5154.80419

12. Sá L, Leitão C, Romariz J, Costa H, Praça F, Pedrosa C. Fixed drug eruption induced by paracetamol – a case report. Acta Sci Paediatr. 2020;3(12):27-9. https://doi.org/10.31080/ASPE.2020.03.0329

13. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009;9(4):316-21. https://pubmed.ncbi.nlm.nih.gov/19474709 https://doi.org/10.1097/ACI.0b013e32832cda4c

14. Phyo YM, Kogilwaimath SK, Chu YF. Paracetamol induced fixed drug eruption in a child. Brunei Int Med J. 2025;21(5):49- 52. https://moh.gov.bn/wp-content/uploads/2025/06/BIMJ2025-21-1-49-52-CR-PCM-fixed-drug-eruption.pdf

15. Pellicano R, Ciavarella G, Lomuto M, Di Giorgio G. Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22. J Am Acad Dermatol. 1994;30(1):52-4. https://pubmed.ncbi.nlm.nih.gov/8277031 https://doi.org/10.1016/s0190-9622(94)70007-9

16. Rutkowski K, Nasser SM, Ewan PW. Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE. Int Arch Allergy Immunol. 2012;159(1):60-4. https://pubmed.ncbi.nlm.nih.gov/22555261 https://doi.org/10.1159/000335213

17. Nino M, Francia MG, Costa C, Scalvenzi M. Bullous fixed drug eruption induced by paracetamol: report of a pediatric case. Case Rep Dermatol. 2009;1(1):56-9. https://pubmed.ncbi.nlm.nih.gov/20652116 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895212 https://doi.org/10.1159/000243728

18. Jain A, Khaire P, Pawar S, Bhandhekar J. Fixed drug eruption induced by paracetamol: uncommon reaction to a common drug. Int J Med Sci Curr Res. 2023;6(3):135-8.

19. Lee AY. Fixed drug eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol. 2000;1(5):277-85. https://pubmed.ncbi.nlm.nih.gov/11702319 https://doi.org/10.2165/00128071-200001050-00003

20. Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA position paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018;29(5):469-80. https://pubmed.ncbi.nlm.nih.gov/29693290 https://doi.org/10.1111/pai.12915

Downloads

Published

11/16/2026

How to Cite

Nuico, R. D., & Andaya, A. (2026). Fixed Drug Eruption: An Underrecognized Cutaneous Adverse Drug Reaction in a 7-Year-Old Male - A Case Report. Philippine Journal of Allergy, Asthma and Immunology, 26(2). https://doi.org/10.70552/pjaai.26.2.18200